Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.105 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.105 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.105 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.105 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.105 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.105 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.105 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.105 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.4 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.4.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.4 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.4.4 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.4.4 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.4.4 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.4 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.4 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.23EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.130EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.130EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.130ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.130ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.130EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.130EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.130ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.130ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.44ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.44ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.469EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.469EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used